Viral Infections
RSSArticles
-
Herpes Simplex Virus 2 Meningitis in Adults
The incidence of herpes simplex virus 2 meningitis in adults in Denmark over a six-year period was 0.7/100,000 population per year, with 91% of cases occurring in the absence of immunocompromise.
-
Understanding Each COVID-19 Test’s Strengths and Weaknesses
Considering that testing over multiple days is not practical in the ED, clinicians with access to relatively rapid RT-PCR testing probably will opt for the more sensitive test. However, the antigen test offers a good option to urgent care centers or EDs that lack access to a sophisticated lab.
-
Booster Doses Effective Against Omicron
While vaccination provides protection against infection with omicron variant of SARS-CoV-2, high level protection from a need for hospitalization requires a booster dose.
-
Omicron: Get Your Booster Dose!
While vaccination provides protection against the omicron variant of SARS-CoV-2, high-level protection from a need for hospitalization requires receipt of a booster dose.
-
Third Documented HIV Remission Case Emerges
Woman with acute myeloid leukemia underwent stem cell transplant, which apparently sent the virus into remission.
-
Multiple Sclerosis and Immune Response to COVID-19 Vaccination
A large group of patients with multiple sclerosis taking various disease-modifying therapies did not respond uniformly to COVID-19 vaccination.
-
U.S. Chlamydia Rates Continue to Climb
The chlamydia infection rate has been rising unabated. While rates of some STIs have fluctuated over the past 40 to 80 years, chlamydia rates have increased progressively since the first reporting data became available in 1984. -
Herpes Vaccine Could Be Available by 2030
Early efforts to produce a protein-based vaccine for herpes failed. But a new mRNA approach has outperformed the efficacy of the past vaccines in preclinical trials and is expected to be introduced in clinical trials in the second half of 2022, investigators say. This new approach for a prophylactic genital herpes vaccine showed great promise in early studies.
-
STI Rates Increasing, but Efficient Testing Can Help
Incidence rates of many sexually transmitted infections (STIs) have increased in the years leading up to the COVID-19 pandemic. There is evidence that STIs have continued to rise during the pandemic, according to the results of a new study. -
FDA Modifies Authorizations for COVID-19 Therapeutics
In the face of the omicron onslaught, certain once-reliable monoclonal antibodies are not as effective.